Found 7 matching trials
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
PHASE4The purpose of this study is to evaluate the clinical efficacy of alpha-blo...
Location
Soon Chun Hyang University Hospital Cheonan
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
PHASE2SRD5A2 is a critical enzyme for prostatic development and growth, and the S...
Location
Beth Israel Deaconess Medical Center
Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
PHASE4This study is designed to investigate the comparison between alpha blocker ...
Location
Samsung Medical Center
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NAThe study objective is to compare water vapor thermotherapy with the REZŪM™...
Status
Active Not Recruiting
Location
Epworth Healthcare
Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan
N/AThis retrospective study aims to assess treatment patterns within 1 year of...
Location
Multiple Locations
Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH
PHASE3The investigators compare the efficacy of alpha-blocker and 5-ARI withdrawa...
Location
Gangnam Severance Hospital, Yonsei University College of Medicine
Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment
N/AThis retrospective study aims to assess the clinical and economic impact of...
Location
Multiple Locations